Policy & Insight

• Policy & Insight
• For Supporters

“Supporting research is mission critical for me and always will be” – Philanthropy award winners share their stories

Jill May and David Dangoor CBE tell us why they’ve devoted time, effort and millions of pounds to back our vital research.   Jill May and David Dangoor CBE tell us why they’ve devoted time, effort and millions of pounds to back our vital research.  

29 November 2021

• Health & Medicine
• Policy & Insight

Opinion: ‘The idea that a tobacco company might profit off my disease appals me’

Hear from a policy manager at Cancer Research UK about what they think about Phillip Morris International's bid for pharmaceutical company Vectura. Hear from a policy manager at Cancer Research UK about what they think about Phillip Morris International's bid for pharmaceutical company Vectura.

1 September 2021

• Health & Medicine
• Policy & Insight

NHS England change of chief executive – what does it mean for cancer?

Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role. Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role.

19 August 2021

• Policy & Insight

Do as I say, not as I do – when the professional becomes personal 

I’ve worked here for over 5 years now. Before that, I worked in the NHS for 6. You’d think I’d be a model patient, so why did I only just learn that I’m absolutely covered in abnormal moles? I’ve worked here for over 5 years now. Before that, I worked in the NHS for 6. You’d think I’d be a model patient, so why did I only just learn that I’m absolutely covered in abnormal moles?

13 July 2021

• Policy & Insight

Turning the Life Sciences Vision into reality

The UK Government recently published their Life Sciences Vision, setting clear targets for supporting UK R&D. Cancer Research UK's CEO, Michelle Mitchell, knows that it requires real investment. The UK Government recently published their Life Sciences Vision, setting clear targets for supporting UK R&D. Cancer Research UK's CEO, Michelle Mitchell, knows that it requires real investment.

9 July 2021

• Policy & Insight

Opinion: ‘The UK must be more ambitious than just clearing the cancer backlog’

Despite staff working flat out, the pandemic has been devastating for NHS cancer services, writes Cancer Research UK's chief clinician. Despite staff working flat out, the pandemic has been devastating for NHS cancer services, writes Cancer Research UK's chief clinician.

24 May 2021

• Health & Medicine
• Policy & Insight

Opinion: ‘Wales needs more than a three-page statement to get cancer services back on track’

The Welsh Government’s decision to publish just a short statement on how it intends to improve patient care over the next 5 years is unacceptable. The Welsh Government’s decision to publish just a short statement on how it intends to improve patient care over the next 5 years is unacceptable.

22 March 2021

• Health & Medicine
• Policy & Insight

Opinion: ‘We’re speaking with One Cancer Voice, but is anyone listening?’

We joined 46 other cancer charities to outline what we need from UK Governments and the NHS coming out of the pandemic to move towards world-leading services. We joined 46 other cancer charities to outline what we need from UK Governments and the NHS coming out of the pandemic to move towards world-leading services.

16 March 2021

• Policy & Insight

Opinion: ‘We need to increase testing in primary care’

Professor Willie Hamilton specialises in primary care diagnostics at the University of Exeter, with a particular expertise in cancer. Professor Willie Hamilton specialises in primary care diagnostics at the University of Exeter, with a particular expertise in cancer.

24 February 2021

• Policy & Insight

Opinion: 'We’re making headway, but we can’t be complacent'

We published our gender and ethnicity pay gap reports today. We published our gender and ethnicity pay gap reports today.

11 February 2021

• Policy & Insight

Opinion: 'Why we need earlier diagnosis of cancer more than ever before'

Professor Georgios Lyratzopoulos leads the Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group and CanTest at University College London. Professor Georgios Lyratzopoulos leads the Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group and CanTest at University College London.

3 February 2021

• Health & Medicine
• Policy & Insight

Opinion: 'Beating cancer means beating it for everyone'

We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, writes Michelle Mitchell. We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, writes Michelle Mitchell.

29 January 2021